Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Nitin Jain, MD, University of Texas MD Anderson Cancer Center, Houston, TX, gives an overview of the Phase II...

Apply to register for the Post-ASH 2021 iwAL Virtual Workshop, featuring key abstracts in ALL, MDS & AML presented...

Luciano Costa, MD, PhD, UAB School of Medicine, Birmingham, AL, discusses findings from the Phase II MASTER trial (NCT03224507),...

Kai Rejeski, MD, LMU Hospital Munich, Munich, Germany, discusses the use of the CAR-HEMATOTOX score to identify patients who...

Andrew Wei, MBBS, PhD, Alfred Hospital and Monash University, Melbourne, Australia, presents the latest findings from the Phase III...

John Burke, MD, Rocky Mountain Cancer Centers, US Oncology Research, Aurora, CO, presents findings from the Phase III POLARIX...

Daniel Pollyea, MD, MS, University of Colorado, Denver, CO, discusses outcomes of treatment-naïve patients with acute myeloid leukemia (AML)...

Registration - 1 day

Mashup Score:3

...

Registration - 3 days

Mashup Score:3

...

Carsten Niemann, MD, PhD, Copenhagen University Hospital, Copenhagen, Denmark, presents results from the prospective, randomized Phase II HOVON-141/VISION trial...

  • HOVON 141/VISION: MRD guided time-limited treatment in CLL Carsten Niemann (@uni_copenhagen) shares the results of the Phase II trial assessing time-limited venetoclax & ibrutinib for R/R #CLL: https://t.co/9PZDZOtE8r #ASH21 #HemOnc #Leukemia #LeuSM #CLLsm #CTSM #TrialUpdate - view on twitter